TNF Inhibitor denied as non-formulary by Florida Blue?

Florida Blue uses Prime Therapeutics or CVS Caremark depending on plan line. Step therapy through preferred biosimilar.

FL Statute 627.42393 limits step therapy when prior failure documented. Demand peer-to-peer review. Cite continuity-of-care for stable patients.

## Why Florida Blue Denies TNF Inhibitors as Non-Formulary

Florida Blue's drug formulary lists covered medications by tier, and specific TNF inhibitors may be excluded from a given plan's formulary or placed at a non-covered tier. Because multiple TNF inhibitor products — both branded reference biologics and their biosimilar equivalents — exist on the market, Florida Blue often covers one or a limited subset while excluding others. A non-formulary denial for a TNF inhibitor typically means your specific prescription was for a product the plan does not list as preferred, even though the drug class itself is covered.

## Why This Denial Is Appealable

Florida Blue, like all ACA-compliant and ERISA-governed plans, is required to maintain a formulary exception process. You may request a formulary exception when a formulary alternative is clinically inappropriate for you — for example, because you have tried and failed a formulary-listed TNF inhibitor, because your prescriber has a clinical reason to prefer one agent over another, or because the on-formulary alternative cannot be substituted without clinical risk. Florida law also provides consumer protections that apply to state-regulated plans.

## Federal Appeal Rights

• Formulary exception request: This is the primary pathway and should be filed immediately. It is distinct from a standard appeal but carries similar procedural rights.
• Internal appeal: If the formulary exception is denied, appeal under ERISA §503 or Florida's insurance code, challenging whether the denial is consistent with accepted clinical practice.
• External review (ACA §2719): After exhausting internal remedies, request independent external review. An external reviewer applies a clinical standard rather than the plan's formulary preference.
• Expedited track: If clinical urgency exists, request expedited formulary exception review. Florida Blue is generally required to act within 72 hours on expedited requests.

## Documentation to Gather

1. Formulary alternatives evaluated: For each TNF inhibitor listed on Florida Blue's formulary, document whether it has been tried (with dates and outcomes) or explain why it is clinically inappropriate for your specific situation. 2. Clinical rationale for the non-formulary agent: Your prescriber should explain the medical basis for choosing the specific non-formulary product — this may involve your diagnosis subtype, established treatment response, biosimilar interchangeability considerations, or administration-route factors. 3. Prescriber letter: A letter addressed to Florida Blue's formulary exception process, citing the relevant specialty-society guideline and stating that formulary alternatives are inadequate or inappropriate for this patient. 4. Florida Blue formulary and exception policy: Download the current year's formulary for your plan and the exception criteria. Respond to each requirement directly. 5. Prior authorization documentation: If a PA was previously approved for a formulary agent that failed, include it — this demonstrates good-faith compliance with the plan's preferred pathway.

## Criteria-Mapping Structure

| Formulary Exception Criterion | Your Supporting Evidence | |---|---| | On-formulary alternative is inappropriate | [Reason — tried and failed / contraindicated / non-interchangeable] | | Clinical need for the specific non-formulary agent | [Prescriber rationale, guideline citation] | | Diagnosis and indication documented | [Chart note, specialist credentials] |

The most persuasive exception requests walk through each formulary alternative and explain — specifically — why each one is not clinically appropriate for this patient. A generic statement that the drug is "medically necessary" without addressing the formulary alternatives is the most common reason exception requests are denied at the first level.